Hepatitis C Virus (HCV) Infection Withdrawn Phase 3 Trials for Ribavirin (DB00811)

Also known as: Hepatitis C (HCV) / HCV Infection / HCV Infections / HCV / Hepatits C / Hepatitis C Virus (HCV) / Hepatitis C Virus / Hepatitis C virus test

IndicationStatusPhase
DBCOND0052122 (Hepatitis C Virus (HCV) Infection)Withdrawn3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01447394Safety and Efficacy Study of Pegylated Interferon Lambda Versus Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis CTreatment